4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-061581
President and CEO sold 11,583 shares at an average $538.65 ($6,239,198)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −131 | $527.88 | $69,152 | 209,198 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −347 | $529.27 | $183,656 | 208,851 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −522 | $530.23 | $276,781 | 208,329 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −368 | $531.99 | $195,772 | 207,961 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −512 | $533.09 | $272,944 | 207,449 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −396 | $534.20 | $211,542 | 207,053 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −644 | $535.27 | $344,715 | 206,409 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −1,040 | $536.11 | $557,557 | 205,369 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −640 | $537.17 | $343,791 | 204,729 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −520 | $538.30 | $279,914 | 204,209 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −215 | $539.03 | $115,891 | 203,994 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −505 | $540.19 | $272,796 | 203,489 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −362 | $541.65 | $196,079 | 203,127 | D |
| Sibold William John President and CEO | 2026-09-09 | Sale 10b5-1 | −160 | $542.55 | $86,808 | 202,967 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −60 | $533.09 | $31,985 | 202,907 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −106 | $534.06 | $56,611 | 202,801 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −218 | $535.94 | $116,836 | 202,583 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −160 | $537.62 | $86,019 | 202,423 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −687 | $540.59 | $371,382 | 201,736 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −368 | $541.64 | $199,324 | 201,368 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −1,202 | $542.60 | $652,209 | 200,166 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −1,539 | $544.02 | $837,253 | 198,627 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −761 | $544.83 | $414,616 | 197,866 | D |
| Sibold William John President and CEO | 2026-09-11 | Sale 10b5-1 | −120 | $546.38 | $65,565 | 197,746 | D |
| Open-market sales · 11,583 sh · avg $538.65 · $6,239,198 | |||||||
Loading xslF345X06/wk-form4_1789160228.xml…